drugset / Trial / NCT01968629
24hr Imaging Of HCC After EOVIST
NaSingle-groupOpen-labelDiagnostic
Summary
In this research study, the investigators are looking to see if MR imaging with Eovist performed 24 hours after the injection of Eovist helps improve the identification and characterization of focal liver tumors.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-07
- Completion
- 2015-07
Outcome
Outcome not reported
Stopped (Enrollment): “No eligible subject enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadoxetate disodium | Diagnostic / imaging agent | 0.1 unknown | — |